N
← Back to Search
Sponsored

Accelerate Your Clinical Trial Recruitment

Reach thousands of high-intent patients matching your specific inclusion criteria.

Start Campaign
RECRUITING Phase 2 ClinicalTrials.gov

A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.

Sponsor: AstraZeneca • ClinicalTrials.gov ID: NCT07652658

Registry updated: 2026-09-21
Ad

Recruiting for Similar Conditions?

Sponsors are looking for patients like you. See if you qualify for compensated research studies.

Check Eligibility →

Description

This Phase IIb study aims to evaluate the efficacy, safety, and tolerability of 3 doses of AZD8965 treatment compared to placebo in participants with IPF, including those on antifibrotic therapy (nintedanib, pirfenidone, nerandomilast), either alone or in combination, or in those not on antifibrotic therapy.

Interventions

  • Placebo for AZD8965 (Other)
    Placebo for AZD8965
  • AZD8965 low dose (Drug)
    AZD8965 low dose
  • AZD8965 medium dose (Drug)
    AZD8965 medium dose
  • AZD8965 high dose (Drug)
    AZD8965 high dose

Eligibility criteria

Inclusion Criteria: 1. Age ≥ 40 years 2. IPF diagnosis 3. Participants with IPF receiving locally approved antifibrotic therapies at a stable dose, or participants with IPF not receiving local standard of care 4. FVC ≥ 45% predicted of normal 5. DLCO corrected for hemoglobin ≥ 25% predicted of normal Exclusion Criteria: 1. ILD other than IPF 2. The extent of emphysema is greater than the extent of fibrotic changes on chest HRCT scan 3. Acute exacerbation of IPF 4. Lower respiratory tract infection requiring treatment 5. Acute coronary syndrome/acute myocardial infarction, unstable angina ± coronary intervention with Percutaneous Coronary Intervention, or Coronary Artery Bypass Grafting 6. Heart failure 7. History of organ transplantation or is likely to receive lung transplantation

Conditions

Idiopathic Pulmonary Fibrosis (IPF)

Locations

  • Research Site — Birmingham, Alabama, United States
  • Research Site — Phoenix, Arizona, United States
  • Research Site — Phoenix, Arizona, United States
  • Research Site — Loma Linda, California, United States
  • Research Site — Los Angeles, California, United States
  • Research Site — Newport Beach, California, United States
  • Research Site — Sacramento, California, United States
  • Research Site — Stanford, California, United States
  • Research Site — Aurora, Colorado, United States
  • Research Site — Denver, Colorado, United States
  • Research Site — Ocala, Florida, United States
  • Research Site — Weston, Florida, United States
  • Research Site — Atlanta, Georgia, United States
  • Research Site — Boise, Idaho, United States
  • Research Site — Champaign, Illinois, United States
  • Research Site — Chicago, Illinois, United States
  • Research Site — Kansas City, Kansas, United States
  • Research Site — Lexington, Kentucky, United States
  • Research Site — Baltimore, Maryland, United States
  • Research Site — Boston, Massachusetts, United States
  • Research Site — Ann Arbor, Michigan, United States
  • Research Site — Detroit, Michigan, United States
  • Research Site — New York, New York, United States
  • Research Site — New York, New York, United States
  • Research Site — Greensboro, North Carolina, United States
  • Research Site — Cincinnati, Ohio, United States
  • Research Site — Oklahoma City, Oklahoma, United States
  • Research Site — Bethlehem, Pennsylvania, United States
  • Research Site — Philadelphia, Pennsylvania, United States
  • Research Site — Philadelphia, Pennsylvania, United States
  • Research Site — Charleston, South Carolina, United States
  • Research Site — Dallas, Texas, United States
  • Research Site — El Paso, Texas, United States
  • Research Site — Houston, Texas, United States
  • Research Site — Burlington, Vermont, United States
  • Research Site — Richmond, Virginia, United States
  • Research Site — Alberdi, Argentina
  • Research Site — Buenos Aires, Argentina
  • Research Site — Ciudad de Buenos Aires, Argentina
  • Research Site — Florida, Argentina
  • Research Site — Rosario, Argentina
  • Research Site — San Fernando, Argentina
  • Research Site — Camperdown, Australia
  • Research Site — Port Macquarie, Australia
  • Research Site — Wollongong, Australia
  • Research Site — Haskovo, Bulgaria
  • Research Site — Plovdiv, Bulgaria
  • Research Site — Rousse, Bulgaria
  • Research Site — Rousse, Bulgaria
  • Research Site — Sofia, Bulgaria
  • Research Site — Sofia, Bulgaria
  • Research Site — Sofia, Bulgaria
  • Research Site — Sherwood Park, Alberta, Canada
  • Research Site — Vancouver, British Columbia, Canada
  • Research Site — Ajax, Ontario, Canada
  • Research Site — Burlington, Ontario, Canada
  • Research Site — Kingston, Ontario, Canada
  • Research Site — North York, Ontario, Canada
  • Research Site — Saint-Charles-Borromée, Quebec, Canada
  • Research Site — Sherbrooke, Quebec, Canada
  • Research Site — Providencia, Chile
  • Research Site — Santiago, Chile
  • Research Site — Talca, Chile
  • Research Site — Viña del Mar, Chile
  • Research Site — Viña del Mar, Chile
  • Research Site — Beijing, China
  • Research Site — Beijing, China
  • Research Site — Beijing, China
  • Research Site — Changchun, China
  • Research Site — Changsha, China
  • Research Site — Chengdu, China
  • Research Site — Chengdu, China
  • Research Site — Guangzhou, China
  • Research Site — Lanzhou, China
  • Research Site — Nanchang, China
  • Research Site — Nanjing, China
  • Research Site — Shanghai, China
  • Research Site — Shenyang, China
  • Research Site — Wuhan, China
  • Research Site — Xuzhou, China
  • Research Site — Zhengzhou, China
  • Research Site — Aarhus, Denmark
  • Research Site — Copenhagen, Denmark
  • Research Site — Hellerup, Denmark
  • Research Site — Odense C, Denmark
  • Research Site — Angers, France
  • Research Site — Brest, France
  • Research Site — Bron, France
  • Research Site — Montpellier, France
  • Research Site — Nice, France
  • Research Site — Paris, France
  • Research Site — Rennes, France
  • Research Site — Tours, France
  • Research Site — Bonn, Germany
  • Research Site — Essen, Germany
  • Research Site — Freiburg im Breisgau, Germany
  • Research Site — Fulda, Germany
  • Research Site — Giessen, Germany
  • Research Site — Hamburg, Germany
  • Research Site — Hanover, Germany
  • Research Site — Heidelberg, Germany
  • Research Site — Hemer, Germany
  • Research Site — Konstanz, Germany
  • Research Site — Leipzig, Germany
  • Research Site — Lübeck, Germany
  • Research Site — Marburg, Germany
  • Research Site — Munich, Germany
  • Research Site — Stuttgart, Germany
  • Research Site — Witten, Germany
  • Research Site — Wuppertal-Barmen, Germany
  • Research Site — Athens, Greece
  • Research Site — Athens, Greece
  • Research Site — Heraklion, Greece
  • Research Site — Ioannina, Greece
  • Research Site — Pátrai, Greece
  • Research Site — Thessaloniki, Greece
  • Research Site — Budapest, Hungary
  • Research Site — Budapest, Hungary
  • Research Site — Debrecen, Hungary
  • Research Site — Törökbálint, Hungary
  • Research Site — Ashkelon, Israel
  • Research Site — Jerusalem, Israel
  • Research Site — Kfar Saba, Israel
  • Research Site — Petah Tikva, Israel
  • Research Site — Rehovot, Israel
  • Research Site — Foggia, Italy
  • Research Site — Forlì, Italy
  • Research Site — Modena, Italy
  • Research Site — Monza, Italy
  • Research Site — Pavia, Italy
  • Research Site — Rozzano, Italy
  • Research Site — Siena, Italy
  • Research Site — Torino, Italy
  • Research Site — Fukuoka, Japan
  • Research Site — Hachioji-shi, Japan
  • Research Site — Hamamatsu, Japan
  • Research Site — Hiroshima, Japan
  • Research Site — Kakogawa-shi, Japan
  • Research Site — Kumagaya-shi, Japan
  • Research Site — Kumamoto, Japan
  • Research Site — Matsusaka-shi, Japan
  • Research Site — Sakaishi, Japan
  • Research Site — Sendai, Japan
  • Research Site — Seto-shi, Japan
  • Research Site — Shimotsuke-shi, Japan
  • Research Site — Shinjuku-ku, Japan
  • Research Site — Yokohama, Japan
  • Research Site — Yokohama, Japan
  • Research Site — Benito Juárez, Mexico
  • Research Site — Chihuahua City, Mexico
  • Research Site — Coyocan, Mexico
  • Research Site — León, Mexico
  • Research Site — Mérida, Mexico
  • Research Site — Monterrey, Mexico
  • Research Site — Monterrey, Mexico
  • Research Site — Oaxaca City, Mexico
  • Research Site — Pachuca, Mexico
  • Research Site — Amsterdam, Netherlands
  • Research Site — Heerlen, Netherlands
  • Research Site — Nieuwegein, Netherlands
  • Research Site — Bialystok, Poland
  • Research Site — Krakow, Poland
  • Research Site — Lodz, Poland
  • Research Site — Poznan, Poland
  • Research Site — Rzeszów, Poland
  • Research Site — Warsaw, Poland
  • Research Site — Cape Town, South Africa
  • Research Site — Durban, South Africa
  • Research Site — Parktown West, South Africa
  • Research Site — Somerset West, South Africa
  • Research Site — Seongnam-si, South Korea
  • Research Site — Seoul, South Korea
  • Research Site — Seoul, South Korea
  • Research Site — Seoul, South Korea
  • Research Site — Seoul, South Korea
  • Research Site — Barcelona, Spain
  • Research Site — Barcelona, Spain
  • Research Site — L'Hospitalet de Llobregat, Spain
  • Research Site — Madrid, Spain
  • Research Site — Málaga, Spain
  • Research Site — Valencia, Spain
  • Research Site — Kaohsiung City, Taiwan
  • Research Site — Kaohsiung City, Taiwan
  • Research Site — Taichung, Taiwan
  • Research Site — Taipei, Taiwan
  • Research Site — Taipei, Taiwan
  • Research Site — Taipei, Taiwan
  • Research Site — Taoyuan, Taiwan
  • Research Site — Yunlin, Taiwan
  • Research Site — Bristol, United Kingdom
  • Research Site — Cottingham, United Kingdom
  • Research Site — Edinburgh, United Kingdom
  • Research Site — Exeter, United Kingdom
  • Research Site — Liverpool, United Kingdom
  • Research Site — London, United Kingdom
Sponsored

Partner with Nurenyx

Showcase your study to thousands of motivated patients matching your criteria.

Learn More

Official Source

Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

View Official Record